Hoplite Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXP
Hoplite Capital Management's SLXP Position: Q2 2015 in Review
Hoplite Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 359,850 shares — an estimated $62.2M sold.
Hoplite Capital Management first reported a position in SLXP in Q3 2014 and held it in 3 quarters. The position peaked at $89.7M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.
- Hoplite Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
- Hoplite Capital Management sold 359,850 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $62.2M.
- Hoplite Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 3 quarters.
- Hoplite Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $89.7M in Q3 2014.
- 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.
Based on Hoplite Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.